Newronika S.p.A., a Milan-headquartered medical technology company specializing in advanced deep brain stimulation (DBS), has secured CE Mark certification for the newest commercial version of its αDBS adaptive DBS system. …
Chronic diabetic wounds are notoriously difficult to treat due to impaired healing, prolonged inflammation, and an elevated risk of infection. In response to this challenge, researchers have created an artificial …
NS Pharma, Inc., headquartered in Paramus, New Jersey, has announced that its parent organization, Nippon Shinyaku Co., Ltd. of Kyoto, Japan, has signed a Sponsored Research Agreement (SRA) with Boston …
EndoDNA, a company specializing in precision health intelligence, has introduced BIOS, an innovative and patented clinical decision-support platform designed exclusively for licensed healthcare professionals. Replacing the company’s previous interpretation engine, …
Insilico Medicine, a clinical-stage biotechnology company specializing in generative artificial intelligence (AI) for drug discovery and development, has announced a strategic research partnership with ASKA Pharmaceutical Co., Ltd. (“ASKA”), a …
Antimicrobial resistance (AMR) poses a major global health threat, affecting millions of people worldwide and potentially causing even greater disruptions to healthcare if left unaddressed. AMR undermines the effectiveness of …
When my uncle John passed away in 1990, my family and I were heartbroken. He had always been the spark in any room, even when he wasn’t physically present. Sadly, …
Gilead has long been at the forefront of HIV research and innovation. We’re excited to announce that our own Moupali Das has received the prestigious AAAS Mani L. Bhaumik Breakthrough …
Picture an individual with Parkinson’s disease calmly enjoying their morning coffee, their hand steady. Or someone living with chronic pain or an overactive bladder finding joy in everyday activities—going to …
In 2006, Tomas Cihlar was well aware that, despite initial successes with combination therapy, HIV continued to be a global challenge with limited treatment options. At the time, he had …
We’re honored to once again be recognized among the top five most just companies in the biopharmaceutical industry in the United States. This recognition highlights our continued dedication to responsible …
To celebrate Women’s History Month, our Identity + Innovation spotlight highlights Devi SenGupta. Discover how her personal journey has influenced her work in advancing new treatments and supporting Gilead’s mission …
Luciana Preger attributes her early exposure to her father’s medical career as a significant influence on her own path in medicine. Now a physician with over two decades of experience …
